Medical and dialytic management of hyperkalemia in hemodialysis patients.
Allon
M
M
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects; D001639:Bicarbonates / Q000008:administration & dosage / Q000627:therapeutic use; D002125:Calcium Gluconate / Q000008:administration & dosage / Q000627:therapeutic use; D005947:Glucose / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006947:Hyperkalemia / Q000209:etiology / Q000503:physiopathology / Q000628:therapy*; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D011188:Potassium / Q000378:metabolism; D006435:Renal Dialysis / Q000009:adverse effects*
D000319:Adrenergic beta-Antagonists; D001639:Bicarbonates; D005947:Glucose; D011188:Potassium; D002125:Calcium Gluconate